Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guopei Luo

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 26, 2016
The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patientsHe Cheng, Guopei Luo, Yu Lu, et al.
Cancer Letters|January 22, 2019
Kras<sup>G12D</sup> mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic cancerHe Cheng, Kun Fan, Guopei Luo, et al.
Pancreas|June 19, 2019
Characteristics and Outcomes of Pancreatic Cancer by Histological SubtypesGuopei Luo, Zhiyao Fan, Yitao Gong, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 30, 2015
Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancerZuqiang Liu, Guopei Luo, Meng Guo, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 10, 2020
Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant ChemotherapyChen Liu, He Cheng, Kaizhou Jin, et al.
Oncology Letters|April 30, 2017
Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumorsGuopei Luo, Chen Liu, He Cheng, et al.
Drug Design, Development and Therapy|March 10, 2015
Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancerKaizhou Jin, Guopei Luo, Zhiwen Xiao, et al.
Cancer Letters|November 15, 2016
CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtypeGuopei Luo, Chen Liu, Meng Guo, et al.
Annals of Surgery|December 5, 2023
Pancreatic Cancer: An Exocrine Tumor With Endocrine CharacteristicsXinzhe Zhu, Zhiwen Xiao, He Liu, et al.
Endocrine|July 5, 2022
Hyperglycemia is associated with adverse prognosis in patients with pancreatic neuroendocrine neoplasmsPin Zhang, Zhiwen Xiao, Huaxiang Xu, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 26, 2016
The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patientsHe Cheng, Guopei Luo, Yu Lu, et al.
Cancer Letters|January 22, 2019
Kras<sup>G12D</sup> mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic cancerHe Cheng, Kun Fan, Guopei Luo, et al.
Pancreas|June 19, 2019
Characteristics and Outcomes of Pancreatic Cancer by Histological SubtypesGuopei Luo, Zhiyao Fan, Yitao Gong, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 30, 2015
Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancerZuqiang Liu, Guopei Luo, Meng Guo, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 10, 2020
Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant ChemotherapyChen Liu, He Cheng, Kaizhou Jin, et al.
Oncology Letters|April 30, 2017
Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumorsGuopei Luo, Chen Liu, He Cheng, et al.
Drug Design, Development and Therapy|March 10, 2015
Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancerKaizhou Jin, Guopei Luo, Zhiwen Xiao, et al.
Cancer Letters|November 15, 2016
CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtypeGuopei Luo, Chen Liu, Meng Guo, et al.
Annals of Surgery|December 5, 2023
Pancreatic Cancer: An Exocrine Tumor With Endocrine CharacteristicsXinzhe Zhu, Zhiwen Xiao, He Liu, et al.
Endocrine|July 5, 2022
Hyperglycemia is associated with adverse prognosis in patients with pancreatic neuroendocrine neoplasmsPin Zhang, Zhiwen Xiao, Huaxiang Xu, et al.
Pageof 9